Akèy › Skizofreni › Arkansas
Etid klinik pou Skizofreni nan Arkansas
21 etid pou Skizofreni ap chèche patisipan nan sit nan Arkansas.
Vil nan Arkansas
Tèks ofisyèl etid la (Anglè)
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Pillar Clinical Research - Bentonville, Bentonville
- Pillar Clinical Research- Little Rock, Little Rock
- Local Institution - 0021, Little Rock
- ak 1 plis
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 28, 2026 · NCT07686263NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Bryant
- Neurocrine Clinical Site, Little Rock
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07114874Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Pillar Clinical Research, LLC, Little Rock
Ap rekriteFaz 3
Laj 5 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT06229210NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Little Rock
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07105098Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
- TG Therapeutics Investigational Trial Site, Little Rock
Ap rekriteFaz 2
Laj 18 a 60 · Tout sèks · Mizajou Sep 23, 2026 · NCT07680946A Study of Brenipatide in Adult Participants With Schizophrenia
- Pillar Clinical Research- Little Rock, Little Rock
Ap rekriteFaz 2
Laj 18 a 55 · Tout sèks · Mizajou Sep 22, 2026 · NCT07410507A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Bryant
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Pillar Clinical Research, LLC, Little Rock
Ap rekriteFaz 1
Laj 18 a 55 · Tout sèks · Mizajou Sep 17, 2026 · NCT07734493A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Woodland International Research Group /ID# 275747, Little Rock
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 15, 2026 · NCT0714591852-week Open Label Safety-Tolerability Study
- Pillar Clinical Research, Bentonville
- Pillar Clinical Research, Little Rock
- Woodland International Research Group, Little Rock
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 9, 2026 · NCT07369154A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Little Rock
- Clinical Site, Little Rock
- Clinical Site, Rogers
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 1, 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- SanRo Clinical Research Group, Bryant
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Little Rock
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Aug 14, 2026 · NCT05303064Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- Pillar Clinical Research LLC, Bentonville
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- Pillar Clinical Research, Bentonville
- Pillar Clinical Research, Little Rock
- Woodland International Research Group, Little Rock
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jul 27, 2026 · NCT07363577A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Woodland International Research Group, Little Rock
Ap rekriteFaz 2
Laj 18 a 55 · Tout sèks · Mizajou Jun 23, 2026 · NCT07191483A Study to Evaluate the Effect of KarXT on Urological Safety
- Pillar Clinical Research- Little Rock, Little Rock
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Jun 3, 2026 · NCT07221877NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Bryant
- Neurocrine Clinical Site, Little Rock
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Mar 6, 2026 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Rogers
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jan 12, 2026 · NCT06961968Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Vanda Investigational Site, Little Rock
Ap rekriteFaz 4
Laj 12 a 17 · Tout sèks · Mizajou Mar 4, 2025 · NCT05648591Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Bentonville
- Reviva site, Little Rock
- Reviva site, Rogers
Ap rekriteFaz 3Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Dec 19, 2024 · NCT05184335Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.